Investing for strong, long term capital growth requires a strategy that invests in stocks that are fundamentally healthy, that can ride out short term volatility and deliver strong capital appreciation over the long-term. We do this by investing in the numbers – applying our quantitative methodology to construct a portfolio of liquid Stock Doctor Star Growth Stocks. These are among the most financially healthy, high quality growth stocks on the ASX that deliver strong long-term capital returns – a great outcome for investors and SMSFs.
Investors seeking strong, long term capital growth shouldn’t look past an Australian growth fund. Actively managed growth funds relieve you of the pressure to know which stock to pick, removing much of hesitation and uncertainty that comes with investing.
The Lincoln Australian Growth Fund consists of an actively managed portfolio of high-quality growth orientated ASX stocks and is suitable for investors seeking strong capital appreciation over a five to ten-year period. As the Lincoln Growth Fund investment manager, we take on all decisions around when to buy, sell, or hold on to the stocks in the growth fund.
The Lincoln Australian Growth Fund leverages our proprietary Financial Health methodology to identifies quality, financially healthy business. This quantitative, systematic approach has a demonstrated track record of outperformance, dating back to its inception in 2005. As a top performing Australian equity fund, the Growth Fund received a 5 Crown Fund Rating from FE fundinfo*.
By investing in quality growth funds like Lincoln Indicators’, you can rest assured that your own financial health is in good hands.
The Lincoln Australian growth fund is actively managed by our experienced team of portfolio managers and analysts, who employ our unique quantitative investment process to deliver results. We believe that investing in a concentration of financially healthy stocks will deliver the best performance outcome to investors over the long-term.
In selecting stocks for our growth funds, we apply our systematic, quantitative methodology in analysing the health of businesses and identifying financially healthy investments with high-growth potential and low risk of failure. This objective, analytical approach was pioneered by our founder, Dr. Merv Lincoln, who sought to incorporate scientific levels of accuracy and predictability into the world of finance. Combined with sophisticated computer technology, our proprietary methodology analyses all 2,000-plus companies listed on the ASX.
If you’re ready to learn more about the growth funds, their historical performance, and out investment methodology, simply get in touch with a member of our team. Our experts are more than happy to answer any questions about any of our services.
*As at 31st August 2020, performance relates to Lincoln Australian Wholesale Growth Fund. The FE AMI Equity Australia – 5 Crown Rating does not constitute investment advice offered by FE and should not be used as the sole basis for making any investment decisions.
All Lincoln Indicators Managed Funds are established to provide investors with maximum peace of mind about the security of their investments. Not only do we invest in financially healthy companies that have a low risk of failure, but we also hold all client investments in a segregated trust with our custodian J.P. Morgan Chase Bank. Furthermore we are regulated by the Australian Securities and Investment Commission (ASIC) in Australia with strict regulatory requirements which govern exactly what we can and can’t do.
|Minimum suggested timeframe||5 years||5 years|
|Minimum initial investment||$250,000||$5,000|
|Minimum additional investment||$5,000||$1,000|
|Management fee (p.a)||0.76%||1.40%|
|Performance fee (p.a.)||20% of outperformance of the benchmark||20% of outperformance of the benchmark|
|Minimum savings plan contribution (optional)||$250 per month||$250 per month|
|Buy/sell spread||0.35% / 0.35%||0.35% / 0.35%|
|Distribution frequency||6 monthly||6 monthly|
|Commencement date||January 2005||June 2007|
No, the Growth Fund has no minimum investment timeframe and you will not be penalised if you decide to redeem your funds within a short period of time. But we suggest a minimum of 5-years to allow an adequate timeframe for the Fund to deliver on its long-term objectives.
The performance fee is 20% of the amount by which the Fund’s performance exceeds the All Ordinaries Accumulation Index. A high-water mark ensures investors do not pay fees until periods of underperformance are fully recouped.
No, our Growth Fund have no up-front or exit fees. This does not take into account buy-sell spreads, which represent the estimated transaction costs incurred when buying or selling underlying assets in relation to investment options. The difference between the investment option buy prices and the sell prices is the total buy-sell spread for that option.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.